Seeking Alpha

FDA accepts test to be used in ARCA Biopharma trial

  • The FDA has accepted LabCorp's (LH) application for its diagnostic test to be used in the Phase 2B/3 "GENETIC-AF" trial of ARCA Biopharma's (ABIO) Gencaro drug for treating patients with atrial fibrillation.
  • Patient enrollment for the testing, in which ARCA is collaborating with Medtronic (MDT) also, is due to begin this quarter.
  • ARCA's shares soar 21%. (PR)
From other sites
Comments (1)
  • pat45
    , contributor
    Comments (397) | Send Message
    Wow cannot believe abio sells for little more than about an overlooked stock. Product looks good and is in p3.
    8 Jan 2014, 10:35 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs